Abstract
Revascularisation of ischaemic tissue remains an area of substantial unmet clinical need in cardiovascular disease. Strategies to induce therapeutic angiogenesis are therefore attractive. Our recent focus has been on human embryonic stem cell (hESC) strategies since hESC can be maintained in a pluripotent state or differentiated into any desired cell type, including endothelial cells (EC), under defined differentiation culture conditions. We recently published a protocol for non-good manufacturing practice (GMP) feeder- and serum-free hESC-EC-directed monolayer differentiation to vascular EC demonstrating the potential to generate hESC-derived EC in a GMP-compliant manner suitable for use in clinical trials. In this study we modified that laboratory protocol to GMP compliance. EC production was confirmed by flow cytometry, qRT-PCR and production of vascular structures in Matrigel®, yielding approximately 30 % mature VE-cadherin+/PECAM-1+ cells using the GMP-compliant hESC line RC13. In conclusion, we have successfully demonstrated the production of vascular EC under GMP-compliant conditions suitable for clinical evaluation.
Similar content being viewed by others
Abbreviations
- GMP:
-
Good manufacturing practice
- EC:
-
Endothelial cells
- hESC:
-
Human embryonic stem cells
- EPC:
-
Endothelial progenitor cells
- N-CAM:
-
Neuronal cell adhesion molecule
- KDR:
-
Kinase insert domain receptor
- PAD:
-
Peripheral arterial disease
- CLI:
-
Critical limb ischaemia
- BM:
-
Bone marrow
- EBs:
-
Embryoid bodies
- MEF:
-
Mouse embryonic fibroblasts
- ATMP:
-
Advanced therapy medicinal products
- bFGF:
-
Basic fibroblast growth factor
- VEGF:
-
Vascular endothelial growth factor
References
Gupta, R., & Losordo, D. W. (2011). Cell therapy for critical limb ischemia: Moving forward one step at a time. Circulation Cardiovascular Interventions, 4(1), 2–5.
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998). Embryonic stem cell lines derived from human blastocysts. Science, 282(5391), 1145–1147.
Reubinoff, B. E., Pera, M. F., Fong, C. Y., Trounson, A., & Bongso, A. (2000). Embryonic stem cell lines from human blastocysts: Somatic differentiation in vitro. Nature Biotechnology, 18(4), 399–404.
Wang, L., Li, L., Shojaei, F., Levac, K., Cerdan, C., Menendez, P., Martin, T., Rouleau, A., & Bhatia, M. (2004). Endothelial and hematopoietic cell fate of human embryonic stem cells originates from primitive endothelium with hemangioblastic properties. Immunity, 21(1), 31–41.
Levenberg, S., Golub, J. S., Amit, M., Itskovitz-Eldor, J., & Langer, R. (2002). Endothelial cells derived from human embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America, 99(7), 4391–4396.
Lu, S. J., Feng, Q., Caballero, S., Chen, Y., Moore, M. A., Grant, M. B., & Lanza, R. (2007). Generation of functional hemangioblasts from human embryonic stem cells. Nature Methods, 4(6), 501–509.
Chen, S. S., Fitzgerald, W., Zimmerberg, J., Kleinman, H. K., & Margolis, L. (2007). Cell–cell and cell–extracellular matrix interactions regulate embryonic stem cell differentiation. Stem Cells, 25(3), 553–561.
Li, Z., Suzuki, Y., Huang, M., Cao, F., Xie, X., Connolly, A. J., Yang, P. C., & Wu, J. C. (2008). Comparison of reporter gene and iron particle labeling for tracking fate of human embryonic stem cells and differentiated endothelial cells in living subjects. Stem Cells, 26(4), 864–873.
Kaufman, D. S., Hanson, E. T., Lewis, R. L., Auerbach, R., & Thomson, J. A. (2001). Hematopoietic colony-forming cells derived from human embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America, 98(19), 10716–10721.
Wang, Z. Z., Au, P., Chen, T., Shao, Y., Daheron, L. M., Bai, H., Arzigian, M., Fukumura, D., Jain, R. K., & Scadden, D. T. (2007). Endothelial cells derived from human embryonic stem cells form durable blood vessels in vivo. Nature Biotechnology, 25(3), 317–318.
Vodyanik, M. A., Bork, J. A., Thomson, J. A., & Slukvin, I. I. (2005). Human embryonic stem cell-derived CD34+ cells: Efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential. Blood, 105(2), 617–626.
Lagarkova, M. A., Volchkov, P. Y., Philonenko, E. S., & Kiselev, S. L. (2008). Efficient differentiation of hESCs into endothelial cells in vitro is secured by epigenetic changes. Cell Cycle, 7(18), 2929–2935.
Prado-Lopez, S., Conesa, A., Arminan, A., Martinez-Losa, M., Escobedo-Lucea, C., Gandia, C., Tarazona, S., Melguizo, D., Blesa, D., Montaner, D., Sanz-Gonzalez, S., Sepulveda, P., Gotz, S., O’Connor, J. E., Moreno, R., Dopazo, J., Burks, D. J., & Stojkovic, M. (2010). Hypoxia promotes efficient differentiation of human embryonic stem cells to functional endothelium. Stem Cells, 28(3), 407–418.
Nourse, M. B., Halpin, D. E., Scatena, M., Mortisen, D. J., Tulloch, N. L., Hauch, K. D., Torok-Storb, B., Ratner, B. D., Pabon, L., & Murry, C. E. (2009). VEGF induces differentiation of functional endothelium from human embryonic stem cells: Implications for tissue engineering. Arteriosclerosis, Thrombosis, and Vascular Biology, 30(1), 80–89.
James, D., Nam, H. S., Seandel, M., Nolan, D., Janovitz, T., Tomishima, M., Studer, L., Lee, G., Lyden, D., Benezra, R., Zaninovic, N., Rosenwaks, Z., Rabbany, S. Y., & Rafii, S. (2010). Expansion and maintenance of human embryonic stem cell-derived endothelial cells by TGFbeta inhibition is Id1 dependent. Nature Biotechnology, 28(2), 161–166.
Cuende, N., & Izeta, A. (2010). Clinical translation of stem cell therapies: A bridgeable gap. Cell Stem Cell, 6(6), 508–512.
Hyun, I., Lindvall, O., Ahrlund-Richter, L., Cattaneo, E., Cavazzana-Calvo, M., Cossu, G., De Luca, M., Fox, I. J., Gerstle, C., Goldstein, R. A., Hermeren, G., High, K. A., Kim, H. O., Lee, H. P., Levy-Lahad, E., Li, L., Lo, B., Marshak, D. R., McNab, A., Munsie, M., Nakauchi, H., Rao, M., Rooke, H. M., Valles, C. S., Srivastava, A., Sugarman, J., Taylor, P. L., Veiga, A., Wong, A. L., Zoloth, L., & Daley, G. Q. (2008). New ISSCR guidelines underscore major principles for responsible translational stem cell research. Cell Stem Cell, 3(6), 607–609.
Kane, N. M., Meloni, M., Spencer, H. L., Craig, M. A., Strehl, R., Milligan, G., Houslay, M. D., Mountford, J. C., Emanueli, C., & Baker, A. H. (2010). Derivation of endothelial cells from human embryonic stem cells by directed differentiation: Analysis of microRNA and angiogenesis in vitro and in vivo. Arteriosclerosis, Thrombosis, and Vascular Biology, 30(7), 1389–1397.
Kane, N. M., Howard, L., Descamps, B., Meloni, M., McClure, J., Lu, R., McCahill, A., Breen, C., Mackenzie, R. M., Delles, C., Mountford, J. C., Milligan, G., Emanueli, C., & Baker, A. H. (2012). Role of MicroRNAs 99b, 181a, and 181b in the differentiation of human embryonic stem cells to vascular endothelial cells. Stem Cells, 30(4), 643–654.
Huang, N. F., Niiyama, H., Peter, C., De, A., Natkunam, Y., Fleissner, F., Li, Z., Rollins, M. D., Wu, J. C., Gambhir, S. S., & Cooke, J. P. (2010). Embryonic stem cell-derived endothelial cells engraft into the ischemic hindlimb and restore perfusion. Arterioscler Thromb Vasc Biol, 30(5), 984–991.
Dar, A., Domev, H., Ben-Yosef, O., Tzukerman, M., Zeevi-Levin, N., Novak, A., Germanguz, I., Amit, M., & Itskovitz-Eldor, J. (2012). Multipotent vasculogenic pericytes from human pluripotent stem cells promote recovery of murine ischemic limb. Circulation, 125(1), 87–99.
Cho, S. W., Moon, S. H., Lee, S. H., Kang, S. W., Kim, J., Lim, J. M., Kim, H. S., Kim, B. S., & Chung, H. M. (2007). Improvement of postnatal neovascularization by human embryonic stem cell derived endothelial-like cell transplantation in a mouse model of hindlimb ischemia. Circulation, 116(21), 2409–2419.
Sone, M., Itoh, H., Yamahara, K., Yamashita, J. K., Yurugi-Kobayashi, T., Nonoguchi, A., Suzuki, Y., Chao, T. H., Sawada, N., Fukunaga, Y., Miyashita, K., Park, K., Oyamada, N., Sawada, N., Taura, D., Tamura, N., Kondo, Y., Nito, S., Suemori, H., Nakatsuji, N., Nishikawa, S., & Nakao, K. (2007). Pathway for differentiation of human embryonic stem cells to vascular cell components and their potential for vascular regeneration. Arteriosclerosis, Thrombosis, and Vascular Biology, 27(10), 2127–2134.
Evseenko, D., Zhu, Y., Schenke-Layland, K., Kuo, J., Latour, B., Ge, S., Scholes, J., Dravid, G., Li, X., MacLellan, W. R., & Crooks, G. M. (2010). Mapping the first stages of mesoderm commitment during differentiation of human embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America, 107(31), 13742–13747.
Stratman, A. N., Davis, M. J., & Davis, G. E. (2011). VEGF and FGF prime vascular tube morphogenesis and sprouting directed by hematopoietic stem cell cytokines. Blood, 117(14), 3709–3719.
Asahara, T., & Kawamoto, A. (2004). Endothelial progenitor cells for postnatal vasculogenesis. American Journal of Physiology Cell Physiology, 287(3), C572–C579.
Jones, E. A., Kinsey, S. E., English, A., Jones, R. A., Straszynski, L., Meredith, D. M., Markham, A. F., Jack, A., Emery, P., & McGonagle, D. (2002). Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells. Arthritis and Rheumatism, 46(12), 3349–3360.
Bi, Y., Stuelten, C. H., Kilts, T., Wadhwa, S., Iozzo, R. V., Robey, P. G., Chen, X. D., & Young, M. F. (2005). Extracellular matrix proteoglycans control the fate of bone marrow stromal cells. Journal of Biological Chemistry, 280(34), 30481–30489.
Osafune, K., Caron, L., Borowiak, M., Martinez, R. J., Fitz-Gerald, C. S., Sato, Y., Cowan, C. A., Chien, K. R., & Melton, D. A. (2008). Marked differences in differentiation propensity among human embryonic stem cell lines. Nature Biotechnology, 26(3), 313–315.
Albelda, S. M., Muller, W. A., Buck, C. A., & Newman, P. J. (1991). Molecular and cellular properties of PECAM-1 (endoCAM/CD31): A novel vascular cell–cell adhesion molecule. The Journal of Cell Biology, 114(5), 1059–1068.
Bach, T. L., Barsigian, C., Chalupowicz, D. G., Busler, D., Yaen, C. H., Grant, D. S., & Martinez, J. (1998). VE-cadherin mediates endothelial cell capillary tube formation in fibrin and collagen gels. Experimental Cell Research, 238(2), 324–334.
Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T., Witzenbichler, B., Schatteman, G., & Isner, J. M. (1997). Isolation of putative progenitor endothelial cells for angiogenesis. Science, 275(5302), 964–967.
Peichev, M., Naiyer, A. J., Pereira, D., Zhu, Z., Lane, W. J., Williams, M., Oz, M. C., Hicklin, D. J., Witte, L., Moore, M. A., & Rafii, S. (2000). Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood, 95(3), 952–958.
Estes, M. L., Mund, J. A., Mead, L. E., Prater, D. N., Cai, S., Wang, H., Pollok, K. E., Murphy, M. P., An, C. S., Srour, E. F., Ingram, D. A., Jr., & Case, J. (2010). Application of polychromatic flow cytometry to identify novel subsets of circulating cells with angiogenic potential. Cytometry Part A, 77(9), 831–839.
Masouleh, B. K., Baraniskin, A., Schmiegel, W., & Schroers, R. (2010). Quantification of circulating endothelial progenitor cells in human peripheral blood: Establishing a reliable flow cytometry protocol. Journal of Immunological Methods, 357(1–2), 38–42.
Schmidt-Lucke, C., Fichtlscherer, S., Aicher, A., Tschope, C., Schultheiss, H. P., Zeiher, A. M., & Dimmeler, S. (2010). Quantification of circulating endothelial progenitor cells using the modified ISHAGE protocol. PLoS One, 5(11), e13790.
Lee, M. J., Kim, J., Lee, K. I., Shin, J. M., Chae, J. I., & Chung, H. M. (2011). Enhancement of wound healing by secretory factors of endothelial precursor cells derived from human embryonic stem cells. Cytotherapy, 13(2), 165–178.
Moon, S. H., Kim, J. S., Park, S. J., Lee, H. J., Do, J. T., & Chung, H. M. (2011). A system for treating ischemic disease using human embryonic stem cell-derived endothelial cells without direct incorporation. Biomaterials, 32(27), 6445–6455.
Rehman, J., Traktuev, D., Li, J., Merfeld-Clauss, S., Temm-Grove, C. J., Bovenkerk, J. E., Pell, C. L., Johnstone, B. H., Considine, R. V., & March, K. L. (2004). Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation, 109(10), 1292–1298.
Acknowledgments
We would like to thank the Technological Strategy Board and the British Heart Foundation for supporting this work. AHB is supported by the British Heart Foundation Chair of Translational Cardiovascular Sciences.
Ethical Standards
These studies were performed with project approval from the UK Stem Cell Bank Steering Committee and in accordance with current guidelines for the use of human embryonic stem cells.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kaupisch, A., Kennedy, L., Stelmanis, V. et al. Derivation of Vascular Endothelial Cells from Human Embryonic Stem Cells Under GMP-Compliant Conditions: Towards Clinical Studies in Ischaemic Disease. J. of Cardiovasc. Trans. Res. 5, 605–617 (2012). https://doi.org/10.1007/s12265-012-9379-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12265-012-9379-2